Reply: EGFR alterations and response to anti-EGFR therapy: is it a matter of gene amplification or gene copy number gain?

被引：3
作者：
Algars, A. [1 ,2 ]
Lintunen, M. [3 ,4 ]
Carpen, O. [3 ,4 ]
Ristamaki, R. [1 ]
Sundstrom, J. [3 ,4 ]
机构：
[1] Turku Univ Hosp, Dept Radiotherapy & Oncol, FIN-20521 Turku, Finland
[2] Univ Turku, MediCity Res Lab, FIN-20520 Turku, Finland
[3] Univ Turku, Dept Pathol, FIN-20520 Turku, Finland
[4] Turku Univ Hosp, Dept Pathol, FIN-20520 Turku, Finland
来源：
BRITISH JOURNAL OF CANCER | 2012年 / 106卷 / 02期
关键词：
COLORECTAL-CANCER PATIENTS; PTEN;
D O I：
10.1038/bjc.2011.571
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：428 / 428
页数：1
相关论文
共 7 条
  • [1] EGFR gene copy number assessment from areas with highest EGFR expression predicts response to anti-EGFR therapy in colorectal cancer
    Algars, A.
    Lintunen, M.
    Carpen, O.
    Ristamaki, R.
    Sundstrom, J.
    [J]. BRITISH JOURNAL OF CANCER, 2011, 105 (02) : 255 - 262
  • [2] A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation
    Cascinu, S.
    Berardi, R.
    Salvagni, S.
    Beretta, G. D.
    Catalano, V.
    Pucci, F.
    Sobrero, A.
    Tagliaferri, P.
    Labianca, R.
    Scartozzi, M.
    Crocicchio, F.
    Mari, E.
    Ardizzoni, A.
    [J]. BRITISH JOURNAL OF CANCER, 2008, 98 (01) : 71 - 76
  • [3] PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients
    Frattini, M.
    Saletti, P.
    Romagnani, E.
    Martin, V.
    Molinari, F.
    Ghisletta, M.
    Camponovo, A.
    Etienne, L. L.
    Cavalli, F.
    Mazzucchelli, L.
    [J]. BRITISH JOURNAL OF CANCER, 2007, 97 (08) : 1139 - 1145
  • [4] Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study
    Moroni, M
    Veronese, S
    Benvenuti, S
    Marrapese, G
    Sartore-Bianchi, A
    Di Nicolantonio, F
    Gambacorta, M
    Siena, S
    Bardelli, A
    [J]. LANCET ONCOLOGY, 2005, 6 (05) : 279 - 286
  • [5] HER2 and Chromosome 17 Effect on Patient Outcome in the N9831 Adjuvant Trastuzumab Trial
    Perez, Edith A.
    Reinholz, Monica M.
    Hillman, David W.
    Tenner, Kathleen S.
    Schroeder, Matthew J.
    Davidson, Nancy E.
    Martino, Silvana
    Sledge, George W.
    Harris, Lyndsay N.
    Gralow, Julie R.
    Dueck, Amylou C.
    Ketterling, Rhett P.
    Ingle, James N.
    Lingle, Wilma L.
    Kaufman, Peter A.
    Visscher, Daniel W.
    Jenkins, Robert B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (28) : 4307 - 4315
  • [6] Potential value of PTEN in predicting cetuximab response in colorectal cancer: An exploratory study
    Razis, Evangelia
    Briasoulis, Evangelos
    Vrettou, Eleni
    Skarlos, Dimosthenis V.
    Papamichael, Dimitrios
    Kostopoulos, Ioannis
    Samantas, Epaminontas
    Xanthakis, Ioannis
    Bobos, Mattheos
    Galanidi, Eleni
    Bai, Maria
    Gikonti, Ioanna
    Koukouma, Alona
    Kafiri, Georgia
    Papakostas, Pavlos
    Kalogeras, Konstantine T.
    Kosmidis, Paris
    Fountzilas, George
    [J]. BMC CANCER, 2008, 8 (1)
  • [7] EGFR alterations and response to anti-EGFR therapy: is it a matter of gene amplification or gene copy number gain?
    Sesbouee, R.
    Le Pessot, F.
    Di Fiore, F.
    Frebourg, T.
    [J]. BRITISH JOURNAL OF CANCER, 2012, 106 (02) : 426 - 427
1